[Therapy of parkinsonism using a combination of L-dopa and decarboxylase inhibitor].
D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors*; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000627:therapeutic use*; D004338:Drug Combinations; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*
D004338:Drug Combinations; D004295:Dihydroxyphenylalanine; D002262:Carboxy-Lyases
Zur Therapie des Parkinson-Syndroms mit einer Kombination zwischen L-Dopa und einem Decarboxylasehemmer.